<![CDATA[Pertumbuhan ikan botia tergolong lambat, memerlukan waktu sekitar enam bulan untuk mencapai ukuran komersial (panjang total 4-5 cm). Penelitian ini bertujuan untuk mengevaluasi respons pertumbuhan benih ikan botia yang diberi hormon pertumbuhan ikan kerapu (rElGH) melalui tiga metode yaitu: perendaman, oral, dan kombinasi perendaman dan oral. Penelitian menggunakan rancangan acak lengkap dan setiap perlakuan diulang tiga kali. Dosis rElGH melalui perendaman yaitu 1,2 mg/L diberikan pada larva umur tujuh hari, sedangkan dosis secara oral yaitu 30 mg/kg pakan dan diberikan pada benih umur tiga bulan. Ikan dipelihara dalam akuarium sistem resirkulasi (80 cm x 40 cm x 25 cm) dengan kepadatan 5 ekor/L selama pemeliharaan tiga bulan pertama dan 1 ekor/L selama pemeliharaan periode tiga bulan kedua. Hasil penelitian menunjukkan bahwa perlakuan kombinasi perendaman dan oral memberikan pertumbuhan yang lebih tinggi sebesar 12,04% dibandingkan kontrol. Perlakuan ini juga meningkatkan level ekspresi insulin-like growth factor-1/ IGF-1 sebesar 29,37% dibandingkan kontrol.The growth of Clown Loach is slow. It takes about six months to reach the market size (4-5 cm total body length). This study aimed to evaluate the growth response of Clown Loach treated with recombinant giant grouper growth hormone (rElGH) delivered by three different methods: immersion, oral, and the combination of immersion and oral. A completely randomized design was used as the experimental design and each treatment was replicated three times. The immersion method used rElGH dose of 1.2 mg/L on seven-day-old larvae, while oral treatment used 30 mg rElGH/kg feed on the three-month-old juvenile. The fish were reared in a closed recirculation tank (80 cm x 40 cm x 25 cm) at a density of 5 fish/L for the first three months, and 1 fish/L for the second three months of rearing period. The result showed that the combination of immersion and oral treatments produced a higher growth rate of 12.04% compared to control treatment. Those treatments also increased insulin-like growth factor-1/IGF-1 expression level about 29.37% compared to the control.]]>
